Patent Assignment
Reel/Frame 054685/0765
Assignment of Assignor's Interest
Recorded: 2020-12-17
Pages: 5
Assignor
NABRIVA THERAPEUTICS IRELAND DAC
Executed: 2020-12-16
Assignee
ZAVANTE THERAPEUTICS, INC.
12670 HIGH BLUFF DRIVE, SAN DIEGO, CALIFORNIA, 92130
Covered Properties
(5)
Methods for Improving Drug Treatments in Mammals
Application:
16/150,254 →
Publication:
US 2019/0134070
Methods for Identifying Novel Dosing Regimens
Methods of Identifying Dosing Regimens
Method for Improving Drug Treatments in Mammals
Method for Improving Drug Treatments in Mammals
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 4, 2015
From: ELLIS-GROSSE, EVELYN J., DR.; AMBROSE, PAUL G., DR.
To: ZAVANTE THERAPEUTICS, INC.
Reel/Frame 036499/0560 →
Assignment of Assignor's Interest
Sep 9, 2015
From: ELLIS-GROSSE, EVELYN J, PHD; AMBROSE, PAUL G, PHD
To: ZAVANTE THERAPEUTICS, INC
Reel/Frame 036525/0097 →
Corrective Assignment to Correct the Second Inventor Document Date Previously Recorded at Reel: 036525 Frame: 0097. Assignor(S) Hereby Confirms the Assignment.
Sep 29, 2015
From: ELLIS-GROSSE, EVELYN; AMBROSE, PAUL
To: ZAVANTE THERAPEUTICS, INC
Reel/Frame 036851/0582 →
Assignment of Assignor's Interest
Jun 13, 2016
From: ELLIS-GROSSE, EVELYN J.; AMBROSE, PAUL G.
To: ZAVANTE THERAPEUTICS, INC.
Reel/Frame 038894/0925 →
Intellectual Property Security Agreement
Dec 20, 2018
From: ZAVANTE THERAPEUTICS, INC
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0152 →
Assignment of Assignor's Interest
Aug 8, 2019
From: ELLIS-GROSSE, EVELYN J.; AMBROSE, PAUL G.
To: ZAVANTE THERAPEUTICS, INC.
Reel/Frame 050005/0963 →
Assignment of Assignor's Interest
May 6, 2020
From: ZAVANTE THERAPEUTICS, INC.
To: NABRIVA THERAPEUTICS IRELAND DAC
Reel/Frame 052593/0933 →
Assignment of Assignor's Interest
May 6, 2020
From: ZAVANTE THERAPEUTICS, INC.
To: NABRIVA THERAPEUTICS IRELAND DAC
Reel/Frame 052593/0772 →
Assignment of Assignor's Interest
May 7, 2020
From: ELLIS-GROSSE, EVELYN J.
To: ZAVANTE THERAPEUTICS, INC.
Reel/Frame 052610/0731 →
Assignment of Assignor's Interest
May 7, 2020
From: ZAVANTE THERAPEUTICS, INC.
To: NABRIVA THERAPEUTICS IRELAND DAC
Reel/Frame 052594/0068 →
Assignment of Assignor's Interest
May 7, 2020
From: ELLIS-GROSSE, EVELYN J.
To: ZAVANTE THERAPEUTICS, INC.
Reel/Frame 052605/0507 →
Assignment of Assignor's Interest
May 11, 2020
From: ZAVANTE THERAPEUTICS, INC.
To: NABRIVA THERAPEUTICS IRELAND DAC
Reel/Frame 052631/0818 →
Assignment of Assignor's Interest
May 11, 2020
From: ZAVANTE THERAPEUTICS, INC.
To: NABRIVA THERAPEUTICS IRELAND DAC
Reel/Frame 052630/0055 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Release of Security Interest
Apr 4, 2023
From: HERCULES CAPITAL, INC.
To: ZAVANTE THERAPEUTICS, INC.
Reel/Frame 063215/0789 →
Release of Security Interest
Jul 20, 2023
From: HERCULES CAPITAL, INC.
To: ZAVANTE THERAPEUTICS, INC.
Reel/Frame 064327/0116 →
Corrective Assignment to Correct the Assignee Zavante Therapeutics, Inc. Previously Recorded on Reel 036499 Frame 0560. Assignor(S) Hereby Confirms the Assignment.
Dec 1, 2023
From: AMBROSE, PAUL G
To: INSTITUTE FOR CLINICAL PHARMACODYNAMICS
Reel/Frame 065741/0411 →
The Submission Is to Correct an Error Made in a Previously Recorded Document That Erroneously Affects the Identified Patent.
May 22, 2024
From: ZAVANTE THERAPEUTICS, INC.
To: ZAVANTE THERAPEUTICS, INC.
Reel/Frame 068464/0111 →
Assignment of Assignor's Interest
Sep 23, 2024
From: ZAVANTE THERAPEUTICS, INC.
To: MEITHEAL PHARMACEUTICALS, INC.
Reel/Frame 068665/0336 →
Assignment of Assignor's Interest
Sep 23, 2024
From: ZAVANTE THERAPEUTICS, INC.
To: MEITHEAL PHARMACEUTICALS, INC.
Reel/Frame 068664/0340 →
Assignment of Assignor's Interest
Sep 23, 2024
From: ZAVANTE THERAPEUTICS, INC.
To: MEITHEAL PHARMACEUTICALS, INC.
Reel/Frame 068664/0352 →